In the early 1980s, Prof. Michal Schwartz, an immunologist, started to explore the cross-talk between the immune and nervous systems.
Application
New therapies for spinal cord injury based on original concepts proposed by Schwartz are being developed and tested in clinical trials by Proneuron, a company in Kiryat Weizmann.